SNS Financial Group’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$186K	–	190
2023 Q4	$186K	Hold	20,000	–	–	0.02%	181
2023 Q3	$131K	Hold	20,000	–	–	0.02%	174
2023 Q2	$163K	Hold	20,000	–	–	0.02%	178
2023 Q1	$171K	Hold	20,000	–	–	0.02%	175
2022 Q4	$185K	Hold	20,000	–	–	0.03%	186
2022 Q3	$206K	Hold	20,000	–	–	0.03%	171
2022 Q2	$200K	Hold	20,000	–	–	0.03%	180
2022 Q1	$246K	Hold	20,000	–	–	0.03%	177
2021 Q4	$347K	Hold	20,000	–	–	0.04%	164
2021 Q3	$359K	Hold	20,000	–	–	0.04%	152
2021 Q2	$457K	Hold	20,000	–	–	0.06%	133
2021 Q1	$299K	Sell	20,000 -50,000	-71%	-$546K	0.04%	158
2020 Q4	$378K	Hold	70,000	–	–	0.06%	133
2020 Q3	$319K	Hold	70,000	–	–	0.05%	148
2020 Q2	$344K	Hold	70,000	–	–	0.06%	133
2020 Q1	$221K	Hold	70,000	–	–	0.05%	168
2019 Q4	$181K	Hold	70,000	–	–	0.03%	205
2019 Q3	$221K	Hold	70,000	–	–	0.05%	176
2019 Q2	$236K	Hold	70,000	–	–	0.05%	176
2019 Q1	$214K	Hold	70,000	–	–	0.05%	167
2018 Q4	$109K	Hold	70,000	–	–	0.03%	180
2018 Q3	$191K	Hold	70,000	–	–	0.05%	167
2018 Q2	$183K	Hold	70,000	–	–	0.05%	163
2018 Q1	$193K	Hold	70,000	–	–	0.05%	155
2017 Q4	$225K	Hold	70,000	–	–	0.05%	153
2017 Q3	$290K	Buy	+70,000	New	+$311K	0.07%	135